Regular follow-up every 3-6 months, assessment of fat-soluble vitamin levels if malabsorption is present, and monitoring for biliary complications are recommended
PubMed ID: 10828840 Gobburu JV et al
Step five: optimize your current protocol Whether you continue on brand name or switch to compounded, use the comprehensive resources available to maximize your results
What This Means If You Are Taking a GLP-1 Medication If you are on semaglutide or tirzepatide and have noticed symptoms that do not appear on the package insert, you are not alone, and those experiences are not automatically irrelevant
Cho Y, et al
This research was supported by funding from Diabetes UK (18/0005884 to JR, RD Lawrence Fellowship 21/0006280 to GM), the Biotechnology and Biological Sciences Research Council (BB/V015869/1 to JJR, BB/R01857X/1 and BB/V016849/1 to LH), the Wellcome Trust Institutional Strategic Support Fund to the University of Aberdeen (to LH and JR)